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 Otto Warburg, a German physiologist, deduced that cancer cells exhibit a 
remarkably different metabolic profile in comparison to normal healthy cells 
characterized by increased rates of glycolysis and lactate fermentation, even in the 
presence of adequate oxygen content. Through the respective gain of function/loss of 
function of oncogenes and tumor suppressor genes, three major genes emerge as 
hallmarks of carcinogenic metabolic reconfiguration; HIF-1a, c-Myc oncogenes, and p53 
tumor-suppressor genes. A result of their respective gain/loss of function are the 
upregulation of several glycolytic proteins and subsequent high rates of glucose influx 
into the tumor microenvironment, as well as lactate production, accumulation, and 
extrusion out of the tumor microenvironment. Patterns of lactate accumulation in 
apparently healthy models upon a progressive exercise bout before and after an exercise 
intervention exist in the structure of Resting, Lactate Thresholds 1 & 2 (LT1/LT2), Onset 
of Blood Lactate Accumulation (OBLA), and Peak parameters. However, it is unclear 
how the structure of these parameters applies to a cancer population and further, between 
cancer survivors actively receiving cancer therapy and cancer survivors who are not. 
Purpose: To investigate blood lactate accumulation response to a progressive exercise 
bout to volitional fatigue before and after a 12-week exercise-based oncology 
rehabilitation intervention between active and inactive cancer survivors. Methods: 21 
 iv 
cancer survivors (active, n=7; inactive, n=14) were invited to participate in a 12 week-
week exercise-based oncology rehabilitation program at the University of Northern 
Colorado Cancer Rehabilitation Institute. All participants performed an initial assessment 
consisting of several physiological parameters, including body composition, pulmonary 
function, balance, muscular strength, muscular endurance, cardiovascular fitness, and 
lactate accumulation (LA). LA was quantified every 2 minutes during a progressive 
treadmill protocol to volitional fatigue via finger stick. The 12-week exercise intervention 
consisted of one-hour exercise sessions with trained Cancer Exercise Specialists focusing 
on cardiovascular endurance, muscular strength and endurance, balance, and flexibility 
exercises. Following the 12 week-exercise based intervention, participants completed a 
reassessment of the same physiological parameters. Results: Resting, Peak, and METS at 
OBLA values of active and inactive cancer survivors before and after an exercise 
intervention were not different (P>0.05). Furthermore, Resting lactate, Peak lactate, and 
METS at OBLA values between active and inactive cancer survivors before and after an 
exercise intervention were insignificantly different (P>0.05). However, both METS at 
OBLA in both active and inactive survivors were significantly different  before and after 
a 12-week exercise intervention (P<0.05). Conclusions: These findings may indicate 
similar responses of lactate handling to exercise training in both active and inactive 
cancer survivors. This outcome is supported by significance of increased METS at OBLA 
of the total subject population before and after a 12-week exercise intervention indicating 
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 Cancer, according to the American Cancer Society, is a disease defined by 
abnormal, uncontrolled cell division and its respective spread to other parts of the body 
through the blood and lymph systems. Several million people are diagnosed with cancer 
each year and that number is expected to continue to increase over the next decade (Bray 
et al., 2017). It is evident that cells naturally consume energy in order to sustain rates of 
proliferation and normal healthy cells have highly orchestrated pathways to efficiently 
recycle metabolites produced as a result of energy utilization. Lactate, ultimately as a 
production of glucose metabolism, is typically shuttled to cells highly capable of 
oxidative phosphorylation, where it is reduced to pyruvate and utilized as an intermediate 
through the Krebs Cycle (Mougios, 2006). In addition, lactate itself is a source of energy 
as well as a signaling molecule for various metabolic adaptations. Cancer cells behave 
differently in that they metabolically reconfigure themselves to support the dysregulation 
of lactate metabolism in an effort to provide a conducive environment pertinent to cancer 
development and progression.   
Otto Warburg, a German physiologist, noted several decades ago that cancer cells 
exhibit a remarkably different metabolic profile in comparison to normal healthy cells 
characterized by increased rates of glycolysis and lactate fermentation, even in the 
presence of adequate oxygen content (Warburg, Wind, & Negelein, 1927). Lactate, as a 




hypothesis until it was recently reintroduced as a metabolite involved with cancer 
signaling mechanisms. Apparently healthy cells must exhibit some aspect of genetic 
mutation in order to be classified as a cancerous cell. These mutations can be a result of 
hereditary and/or environmental influences, however it is necessary for a cell to 
experience two separate “hits” to be classified as a cancerous cell, as according to the 
“multiple hit theory” (Ashley, 1969). Cells contain oncogenes, which aid in the 
regulation of genes and proteins necessary for cell growth, and tumor-suppressor genes, 
which aid in halting cell proliferation and promoting apoptosis or “programmed cell 
death” (Fearon & Bommer, 2008). Together, these genes aid in the regulation and 
prevention of these carcinogenic hits and it is when these genes experience a respective 
gain (GOF) or loss of function (LOF) due to hereditary or environmental influences, they 
become dysregulated, thus promoting abnormal and uncontrolled cell division (Ringer & 
Schnipper, 2001). HIF-1𝛼 and p-53 oncogenic GOF along with c-Myc LOF are believed 
to play a role in carcinogenic regulatory mechanisms and have consistently been 
associated with cancer aggressiveness and poor prognosis (Brizel et al., 2001; Kunkel et 
al., 2003; Unruh et al., 2003; Younes, Brown, Stephenson, Gondo, & Cagle, 1997)  
Together, the respective GOF and LOF of these oncogenes and tumor-suppressor 
gene have led to the identification of important steps related to lactagenesis, the 
production of lactate, and its subsequent relation to cancer aggressiveness. The mutation 
of these regulatory genes first leads to an increased expression and activity of glycolytic 
enzymes including glucose transporters (GLUT), catabolic glycolytic intermediates such 
as pyruvate dehydrogenase kinases and lactate dehydrogenase enzymes, and its 




metabolites for energy synthesis through the Krebs cycle (De Saedeleer et al., 2012; 
Firth, Ebert, & Ratcliffe, 1995; Levine & Puzio-Kuter, 2010; Osthus et al., 2000). Lactate 
produced as a result of anaerobic glycolysis, even in the presence of oxygen, is not 
shuttled into the mitochondria for oxidative phosphorylation through the Krebs cycle but 
rather accumulates and is extruded via the upregulation of monocarboxylate transport 
proteins (Shi et al., 2001). This extrusion of lactate and its associated hydrogen proton 
reduces pH levels of the tumor microenvironment and stimulates acidosis-induced 
upregulation of vascular endothelial growth factor (VEGF), leading to increased rates of 
glucose delivered to the tumor itself (Polet & Feron, 2013; Sonveaux et al., 2012). Brizel 
et al., (2001) noted that blood lactate concentrations of cancer survivors were up to 40% 
higher in 34 newly diagnosed cancer patients than that of an apparently healthy 
population and that these high blood lactate concentrations were associated with the 
subsequent development of distant metastasis and tumor aggressiveness.  This cycle of 
increased glycolytic enzyme expression/activity, glucose uptake and subsequent lactate 
production, accumulation, and release is constantly repeated throughout the process of 
tumorigenesis, which explains the findings of high lactate levels of cancer cells and its 
association with cancer metastasis and poor prognosis.   
Recent studies investigated the effects of exercise on gene structure and integrity 
to modulate the mutations of proto-oncogenes and tumor-suppressor genes associated 
with carcinogenesis and related lactate production (Abe et al., 2015; Gohil & Brooks, 
2012; Safdar et al., 2015). Exercise facilitates proper production, accumulation, and 
disposal of lactate and the upregulation of lactagenic intermediates in apparently healthy 




metabolism. As exercise has been used to modulate cell-to-cell transport mechanisms of 
glucose and lactate in diabetic models (Juel, Holten, & Dela, 2004), it is plausible to infer 
that exercise may regulate similar mechanisms in cancer survivors.   
Statement of Purpose 
The purpose of this study was to compare blood lactate accumulation response to 
a progressive exercise bout to volitional fatigue before and after a 12-week exercise-
based oncology rehabilitation intervention between cancer survivors currently undergoing 
cancer treatment and cancer survivors not undergoing cancer treatment.  
Research Hypotheses 
H1 Cancer survivors in treatment will have lower resting blood lactate levels 
than cancer survivors out of treatment before and after a 12-week exercise 
intervention. 
H2 Cancer survivors in treatment will reach OBLA at a lower METS than 
cancer survivors out of treatment before and after a 12-week exercise 
intervention. 
H3 Cancer survivors in treatment will have lower peak blood lactate 
accumulation levels than cancer survivors out of treatment before and after 
a 12-week exercise intervention. 
Need for the Study 
As cancer rates and research on cancer as a metabolic disease continue to rise, 
comprehending the aspect of cancer metabolism becomes all the more prevalent. It is 
clear that oncogene and tumor-suppressor gene dysregulation lead to increased rates at 
which tumors metabolize carbohydrates and subsequent dysregulated lactate handling 
(Boidot et al., 2012; Sonveaux et al., 2012; Ullah, Davies, & Halestrap, 2006). 
Ultimately, dysregulated lactate handling in cancer survivors with HIF-1𝛼/c-Myc GOF 




Sonveaux et al., 2012). Research in cancer biology lacks information on blood lactate 
parameter response to an exercise intervention. Since lactate production, accumulation, 
and disposal may be regulators of cancer aggressiveness and key indicators of poor 
prognosis, it is pertinent to understand how lactate accumulates in cancer survivors. 
There are currently no studies that have investigated blood lactate parameters during a 
progressive exercise bout to volitional fatigue in cancer survivors and it is unclear how 













REVIEW OF LITERATURE 
 
Cancer, one of the leading causes of death worldwide, is characterized as “a 
disease in which abnormal cells divide without control and… spread to other parts of the 
body through the blood and lymph systems” (National Program of Cancer Registries, 
2018). Over 18 million people were diagnosed with cancer in 2018 according to 
incidence data compiled by the World Health Organization and International Agency for 
Research on Cancer, (Forman, Ferlay, Stewart, & Wild, 2014). As the mechanisms of 
cancer start to become more heavily explored, one clear characteristic that continues to 
emerge is the aspect of cancer metabolism and its anabolic/catabolic function(s). 
 In order for cancer cells to maintain high rates of proliferation they must produce 
and utilize large amounts of nutrient, specifically glucose, efficiently. Healthy, normal 
cells coordinate with several regulatory genes, specifically tumor-suppressor genes and 
oncogenes, in a highly orchestrated series of pathways in order to proliferate properly and 
maintain genetic stability. Tumor-suppressor genes exist to halt the cell cycle and/or 
promote apoptosis, or programmed cell death, whereas oncogenes help regulate cell 
growth and cell differentiation (Fearon & Bommer, 2008). As a healthy cell develops 
mutations to either of these gene types, the cell loses its ability to repair mistakes in DNA 
and prevent abnormalities along the development of the cell cycle. Through a series of 
simultaneous activation and inactivation of these oncogenes and tumor-suppressor genes, 




multiple mutations, or “hits,” to cause a change in the phenotype of the cell. The 
dysregulations of these genes due to the mutations of a gene itself, or by 
hereditary/environmental influences is referred to as the “multiple hit theory” (Ashley, 
1969). 
Cancer Metabolism Dysfunction 
 As a healthy cell develops a cancerous identity, it is genetically modified to better 
exist in hypoxic or anaerobic conditions characterized by “accelerated glycolysis and 
excessive lactate formation...even under fully oxygenated environments” instead of 
utilizing a more effective pathway of oxidative phosphorylation to yield sufficient ATP. 
This phenomenon was discovered in 1923 by a German physiologist, Otto Warburg, and 
was appropriately termed “the Warburg effect” (Warburg et al., 1927). It is noted in 
current literature that a triad of glycolytic enzymes, specifically hypoxia-inducible 
transcription factor-1 alpha (HIF-1𝛼), c-Myc, and p53, are heavily involved in why/how 
cancerous cells favor a glycolytic flux (Yeung, Pan, & Lee, 2008). 
Dysregulation of Glycolytic Factors  
Transcription factor HIF-1α, a proto-oncogene, responds to low oxygen 
microenvironments by activating transcription genes for glucose and lactate transporters 
(Semenza, 2010). Pathways involved in activating HIF-1α include Ras/Raf/MAPK and 
PI3-K/Akt pathways (Minet, Michel, Mottet, Raes, & Michiels, 2001). Genes activated 
by HIF-1α gain of function (GOF) or overexpression include pyruvate dehydrogenase 
kinase-1 (PDHK-1) and glucose transporter GLUT-1. GLUT-1 has a high affinity for 
glucose and plays a significant role in tissues that are highly dependent on glucose for 




dehydrogenase, thus phosphorylating and inactivating pyruvate dehydrogenase (PDH) 
(Brooks, 2009). The inactivation of PDH limits the amount of pyruvate that is shuttled to 
mitochondria and oxidized to acetyl-CoA and instead, further favors shuttling to the 
glycolytic flux via gluconeogenesis, the synthesis of glucose from non-carbohydrate 
carbon substances. In short, lactate can be reutilized for ATP synthesis by converting it 
back into glucose (Semenza, 2007). In addition to PDHK-1 and GLUT-1, another key 
enzyme that is overexpressed via HIF-1α mediated downstream regulation is lactate 
dehydrogenase isoform A (LDHA), which favors the reduction of pyruvate to lactate 
while also yielding a necessary substrate, NAD+, under highly glycolytic environments 
(Firth et al., 1995; McCleland et al., 2012).  
As with HIF-1α, c-Myc gene expression is also mediated through Ras/Raf/MAPK 
and PI3-K/AKT signaling pathways (Cairns, Harris, & Mak, 2011). c-Myc 
overexpression, another major oncogenic target of cancer metabolism, is also partly 
responsible for many of these carcinogenic shifts. In normal cells, c-Myc is very highly 
regulated in order to insure its efficiency in positively regulating the expression of 
numerous genes involved with cellular proliferation and metabolism. In cancer cells, 
oncogenes including c-Myc experience a “gain of function” (GOF) in which the 
oncogene ignores signals that stop cell growth by inducing apoptosis and instead 
accelerate tumor development (Pelengaris, Khan, & Evan, 2002). c-Myc GOF accelerates 
the level of expression of genes such as GLUT-1 and LDHA (Shim et al., 1997). Similar 
to HIF-1α, which also overexpresses GLUT-1 and LDHA, c-Myc induced overexpression 
of GLUT-1 results in an increased amount of glucose that is shuttled into the tumor 




(Osthus et al., 2000). Because of the HIF-1α mediated activation of PDHK-1, the high 
levels of lactate produced as a result of accelerated glucose influx are not dispelled into 
mitochondria to be oxidized to acetyl-CoA, but instead are converted back to glucose via 
the Krebs cycle (De Saedeleer et al., 2012; Shim et al., 1997). 
p53, a tumor suppressor gene, regularly functions to shift away from the 
glycolytic flux and promote oxidative phosphorylation by repressing the expression of 
glucose transporters GLUT-1 and GLUT-4 while also upregulating mitochondrion 
proteins, which would further promote oxidative phosphorylation (Safdar et al., 2015). In 
addition to regulating protein expression critical to regulating normal cell metabolism, 
p53 modulates apoptosis in the presence of low glucose levels. Tumor suppressor genes 
experience a loss of function (LOF) where mutations to the gene prevent its role in 
regulating mechanisms (Vogelstein & Kinzler, 2004). As a result, in tumorigenesis, p53 
loses its ability to repress expression of glucose transporters, which facilitates a highly 
glycolytic environment. In highly glycolytic environments, p53 ceases to activate 
apoptosis as well (Bensaad et al., 2006).  
Lactate Mediated Angiogenesis 
 In addition to these metabolic enzymes necessary for carcinogenesis, a group of 
proteins that are highly expressed by HIF-1α/c-Myc GOF and p53 LOF are 
monocarboxylate transport proteins (MCT). MCT’s are instrumental in facilitating lactate 
extrusion from cancer cells to the tumor microenvironment and vice versa, and their 
expression is heavily upregulated upon oncogenic GOF/tumor suppressor gene LOF. 
Whereas oncogenic dysfunction leads to upregulation of MCT4’s which primarily 




upregulation of MCT1’s, which primarily facilitate lactate influx into a cell (Boidot et al., 
2012; Ullah et al., 2006). This step of lactagenisis is key as lactate extrusion stimulates 
vascular endothelial growth factor (VEGF) expression leading to increased rates of 
angiogenesis, the development of new blood vessels, and respective tumor growth 
(Sonveaux et al., 2012). With increased vasculature to the tumor, there is an increased 
influx of glucose and other metabolites useful for cell growth and proliferation into the 
tumor as well as the subsequent flush of excess metabolites, including lactate, from the 
environment involved with the tumor. HIF-1α and c-Myc oncogenes as well as p53 
tumor-suppressor gene all seem to behave geometrically in that their respective gains and 
losses of function all coincide with another to contribute directly to the Warburg effect; 
the high affinity of carcinogenic cells to convert glucose to pyruvate even in the presence 
of adequate oxygen content (Warburg et al., 1927). Patients who express high levels of 
any combination of these genes have significantly increased mortality rates which is 
likely due to an increased aggressiveness of their cancer (Brizel et al., 2001; Kunkel et 
al., 2003; Unruh et al., 2003; Younes et al., 1997). Collectively, as a result of HIF-1α, c-
Myc GOF, and p53 LOF, respective up/downregulation of PDHK-1, PDH, LDHA, 
glucose transporters, and MCT’s harmoniously interact with each other to favor a 
glycolytic flux by increasing glucose concentration in the tumor microenvironment while 
also preventing lactate oxidation to pyruvate, as well as facilitating proper extrusion of 
lactate from cancer cells into the tumor microenvironment. A result of this carefully 
coordinated production, accumulation, and release of lactate is the stimulation of 




Lactate has historically been regarded as a waste product of energy metabolism. 
However, it has become increasingly evident that lactate is a key player in cancer 
prognosis and aggressiveness not because of its role in pH acidification of cancer cells 
and the tumor microenvironment but because of its role as a signaling molecule involved 
with different mechanisms sustaining cancer cell survival, proliferation, and metastasis 
(Gottfried, Kreutz, & Mackensen, 2012). Cancer-mediated lactagenesis, the generation or 
production of lactate through the initiation of gene mutations, behaves in a circular 
pattern leading to metabolic reprogramming and the increased accumulation and disposal 
of lactate in the tumor microenvironment. The coordination of HIF-1α/c-Myc GOF and 
p53 LOF results in an increase in glycolytic enzyme expression and activity and therefore 
an influx of glucose uptake by the tumor microenvironment (Bensaad et al., 2006; 
Brooks, 2009; Shim et al., 1997).  Because lactate oxidation to pyruvate is repressed in 
tumor cells, this increased glucose uptake is characterized by increased lactate production 
and accumulation through a catabolic process known as anaerobic glycolysis. Through 
the catabolism of a glucose molecule, ultimately, two molecules of lactate are produced 
while also yielding an oxidized dinucleotide, NAD+, essential to sustaining rapid rates of 
glycolysis and redox homeostasis, which is what is seen in strenuous exercise (Dang & 
Semenza, 1999). It is important that NAD+ is produced intracellularly as these 
dinucleotides do not diffuse across cellular membranes easily. Cancer metabolism is 
inherently similar to that of Type IIB/IIX skeletal muscle fiber in that high rates of 
glycolysis continue to yield high rates of NAD+, which is then utilized to continue higher 
rates of glycolysis and its accompanied lactate production (Semenza et al., 1996). With 




increase in lactate extrusion as well as lactate-mediated angiogenesis through VEGF. As 
more blood, and glucose, cycle through the tumor microenvironment, more glucose is 
metabolized, therefore continuing the cycle of cancer-mediated lactagenesis while also 
providing a favorable milieu for tumor cell growth and survival.   
Lactate and Exercise 
As the rate of ATP demand exceed ability to provide that ATP aerobically, energy 
production switches from primarily oxidative phosphorylation to primarily aerobic and 
anaerobic glycolysis. It is well established that oxidative phosphorylation is far more 
efficient in yielding the necessary amount of energy, approximately 36 molecules of 
adenosine triphosphate (ATP) per molecule of glucose, for muscular contraction and 
movement during exercise, but the issue is that oxidative phosphorylation demands a 
much more extensive time component. Anaerobic glycolysis can only yield up to two 
molecules of ATP, but in just a fraction of the time. This energy molecule, ATP, is 
required for a number of metabolic processes, including skeletal muscle contraction, and 
it is this swift switch to anaerobic metabolism that leads to an abrupt increase in lactate 
and its paired hydrogen ion. Lactate accumulation in skeletal muscle is traditionally 
associated with a burning sensation related to several theories of muscle fatigue and 
limitations of exercise performance. It is well known that lactate and its associated 
hydrogen ion contribute to impairments in muscle contractility. Upon the onset of high 
intensity exercise, the energy demand for myosin-actin crossbridge cycling and increased 
myosin adenosine triphosphatase (ATPase) activity must be met through anaerobic 
metabolic processes because aerobic metabolic processes require too much time. When 




being shuttled to slow oxidative muscle fiber that contain high densities of mitochondria 
via MCT’s, is converted to lactate to yield an oxidized NAD+ to promote energy 
production via a glycolytic flux. Several frog, rodent, and human studies have shown that 
intracellular hydrogen ions derived from lactate production often disassociate and impair 
production of metabolic proteins such as phosphocreatine and phosphofructokinase, 
necessary for energy production in an oxygen-lacking environment, known as 
intramuscular acidosis (Sahlin, 1986). Additionally, Donaldson, Hermansen, & Bolles 
(1978) and Westerblad, Bruton, & Lännergren (1997) conducted individual studies in 
which rat muscles predominant in fast twitch fibers were connected to a force transducer 
and stimulated to induce tetanic contractions and the onset of fatigue. Maximal forces 
were measured at each stimulation and researchers found that force production as well as 
shortening velocity both decreased as intramuscular pH levels decreased. Intramuscular 
acidosis, according to Balog & Fitts (2001), has been shown to affect the rates of 
sarcoendoplasmic reticulum calcium ATPase (SERCA) Ca2+ release and reuptake to/from 
crossbridge binding sites, thus limiting the rate of crossbridge formation during exercise 
(Favero, Zable, Bowman, Thompson, & Abramson, 1995). Even further, it has been 
shown that hydrogen protons can bind to myosin ATPase binding sites themselves on 
myosin heavy chain muscle fiber(s), further impairing the rate of crossbridge formation 
and cycling, thus reducing force output and muscle fiber shortening velocity.  
Blood Lactate Parameters During Exercise 
Lactate production, accumulation, and disposal during exercise has distinct 
characteristics during exercise that have been quantified. Lactate as a byproduct of 




into vasculature and thus, a resting level of blood lactate accumulation exists at all times 
typically ranging from 0.9 to 1.5 mmol/L (Tesch, Sjodin, & Karlsson, 1978). It is a 
heavily recycled metabolite, reutilized by tissue in the liver, kidneys, heart, brain, and 
adjacent skeletal muscle and is extruded into the vasculature at higher rates during 
exercise, depending on the glycolytic capacity of the working muscles (Van Hall, 2010). 
A valid and reliable method of measuring lactate extrusion into the vasculature during 
exercise is the use of blood lactate analyzers, similar to diabetic blood glucose meters. 
Depending on the type of muscle and the exercise intensity, as well as whether the 
individual is trained or untrained, high levels of blood lactate accumulation can occur 
sooner into an exercise bout rather than later due to the aerobic capacity of different 
muscle fiber. Type IIB/X muscle fibers have less mitochondrial density and thus, a lower 
aerobic capacity to shuttle pyruvate into mitochondria to be utilized via oxidative 
phosphorylation and so the onset of lactate accumulation would occur faster (Adeva-
Andany et al., 2014). As exercise intensity increases, the metabolic demand for energy or 
ATP increases. ATP synthesis is a direct product of anaerobic and aerobic glycolysis, and 
lactate is formed amongst many other metabolites. As the body’s metabolic demand 
increases, cardiovascular activity increases as does the rate at which blood flows 
throughout the vasculature. The amount of lactate, and other metabolites, produced and 
diffused into the blood stream increases. This increased value of blood lactate can help 
clinicians or even coaches determine at what intensity or metabolic equivalent (MET) the 
individual or athlete is working by establishing the individuals’ Lactate Threshold 1 
(LT1), or the moment at which there is a sustained increase in blood lactate above resting 




accumulation indicating an equilibrium between lactate production and lactate 
elimination. Determining an individual’s onset of blood lactate accumulation (OBLA), 
which refers to the exercise intensity, or METS, that blood lactate begins to exponentially 
increase, can also help a professional determine what specific types of exercise 
modalities to incorporate into their programming. (Adeva-Andany et al., 2014; Stegmann, 
Kindermann, & Schnabel, 1981).  
Blood Lactate Parameter Adaptation  
Response to Exercise  
As it is important to understand how and why populations reach different blood 
lactate parameters at different percentages of their maximal oxygen uptake, it is also 
important to understand how mechanisms of lactate production, accumulation, and 
disposal adapt to exercise training. At higher intensities or METS, the capacity of which 
ATP is derived to sustain the intensity of exercise shifts from an aerobic capacity to an 
anaerobic capacity (Mougios, 2006). Typically, glucose is broken down into ATP and 
pyruvate via glycolysis; the pyruvate produced is shuttled into adjacent non-exercising 
tissue such as the heart, liver, kidneys, brain, and non-working skeletal muscle where 
pyruvate is degraded further for energy production via oxidative phosphorylation (Essen, 
Pernow, Gollnick, & Saltin, 1975; Naughton & Hellerstein, 1973). The rate at which an 
individual consumes and utilizes oxygen can determine at what intensities there might be 
a shift from aerobic to anaerobic metabolism for energy production during exercise. This 
implies that as exercise intensity increases, the rate of which lactate accumulates in the 
blood succeeds the rate at which blood lactate is resorbed and that the demand for ATP 
cannot be met through oxidative phosphorylation. With exercise training there is an 




in catabolizing tissue, and the ability to recycle said lactate for oxidative phosphorylation 
(Bassett & Howley, 2000).  
The present study utilizes METS, the amount of oxygen consumed/utilized 
multiplied by the resting value, 3.5 ml/kg/min, to measure improvement of exercise 
tolerance and buffering of lactate accumulation with increasing intensity of exercise. 
With the intervention of exercise, as is seen with apparently healthy populations, an 
individuals’ capacity to consume oxygen with the goal of producing energy through 
aerobic means would improve. With an exercise-mediated improved ability to consume 
and utilizing oxygen, an individual would achieve OBLA at higher intensities, and 
METS, of exercise due to subsequent improvements in buffering lactate through 
oxidative mechanisms (Jette, Sidney, & Blümchen, 1990). The question with cancer 
populations, who express dysfunctions in metabolic behavior, is if they would respond 
similarly to exercise in terms of lactate buffering at higher intensities or METS during an 
exercise bout to volitional fatigue.  
Endurance Training  
A change in lactate parameters of resting, LT1 and LT2, OBLA, and peak blood 
lactate accumulation levels would signify a physiological adaptation in how an individual 
efficiently produces, accumulates, and disposes of lactate from tissue actively utilizing 
energy. Research has shown endurance training induced increases in HIF-1α oncogene 
expression (Abe et al., 2015) as well as mRNA expression and translocation of GLUT-1 
& 4 glucose transporters, facilitating high rates of glucose uptake in skeletal muscle as 
well as increased insulin sensitivity in diabetic patients (Pouysségur, Dayan, & Mazure, 




transporters, endurance training also increases MCT1 & MCT4 content allowing for 
increased extrusion and cell-to-cell uptake of lactate during exercise according to a rat 
study conducted by Aveseh, Nikooie, & Aminaie (2015). This same study also monitored 
LDH enzymes and showed increased expression in LDH-B enzymes and decreased 
expression in LDH-A enzymes, facilitating lactate to pyruvate oxidation for further 
oxidative phosphorylation while also preventing pyruvate reduction to lactate, thus 
buffering the accumulation of lactate extruded into the vasculature (Bishop, Edge, 
Thomas, & Mercier, 2008). p53 tumor-suppresor genes were also monitored in a study by 
Safdar et al., (2015). The study reported a reduction in mitochondrial DNA mutation and 
increased rates of oxidative phosphorylation with the intervention of endurance exercise 
in aging mice. It is also noted that exercise-induced lactate shuttles are ‘sensed’ by the 
proto-oncogenic Myc network, thus stimulating the production of glucose transporters 
and glycolytic enzymes necessary for improved lactate handling during exercise. As 
exercise intensity increases, c-Myc oncogenes sense the increase in redox-modulating 
metabolites such as NAD+ and lactate handling in order to promote the upregulation of 
necessary glycolytic intermediates, allowing for increased lactate production, 
accumulation, and disposal (Gohil & Brooks, 2012).  
Resistance Training 
Far less information exists on the implications of resistance exercise training and 
oncogenic/tumor-suppressor gene regulation as well as its relationship with glycolytic 
enzyme expression. Some resistance training studies in humans have shown upregulation 
of glucose transporter isoforms 1 and 4 as well as lactate dehydrogenase enzymes 




proteins also seem to be upregulated with resistance training. A study investigating the 
relationship between MCT 1 and 4 protein expression and resistance training in diabetic 
patients reported that MCT content is typically reduced in diabetic patients, however this 
reduction can be attenuated with resistance training (Juel et al., 2004). Resistance training 
did, although, increase MCT content in skeletal muscle fiber of healthy adult males. 
Lactate and Cancer Therapies 
Lactagenic intermediates and symporters have also been shown to increase during 
bouts of chemotherapy and radiation, suggesting the increased mobilization of lactate 
during typical cancer therapies. Several studies show the increased regulation of LDHA 
and B isoforms as well as both MCT1 and 4 isoforms, facilitating the production, 
accumulation, and disposal of lactate for carcinogenic proliferation (McCleland et al., 
2012; McCleland et al., 2013). The targets of these chemotherapeutic drugs and radiation 
are to eliminate the dysregulation of HIF1α/c-Myc oncogenic and p53 tumor-suppressor 
gene expression. A combination of both endurance and resistance exercise modalities 
seems to modulate HIF-1α oncogenic and p53 tumor suppressor gene expression as well 
as glycolytic enzymes and transport proteins involved with lactate production, 
accumulation, and disposal. An increase in lactate production and extrusion also 
stimulates c-Myc expression, further promoting lactate production through the glycolytic 
flux. Through HIF-1α, c-Myc, and p53 mediated upregulation of glucose transporters and 
glycolytic intermediates shifting metabolic regulation towards lactagenesis, it may be 
plausible to infer improved lactate handling in both apparently healthy and cancer 
populations at similar METS through the application of endurance and/or resistance 




growth from the tumor microenvironment and instead allocate blood flow to working 
skeletal muscle and other tissues. In addition, exercise mediated regulation of glycolytic 
proteins and its subsequent regulation of lactate production, accumulation, and disposal 
may shunt lactate as a metabolic regulator in tumorigenesis. 
Resting Lactate in Cancer Survivors 
It is important to note in a study conducted by Brizel et al., (2001) that lactate 
concentrations in head and neck cancer survivors were up to 40% higher than that of an 
apparently healthy population. Because the process of lactagenesis and its accompanied 
glycolytic intermediates are so heavily upregulated, the facilitation of glucose into the 
tumor and its subsequent lactate production, accumulation, and extrusion is enhanced. 
Resting lactate levels of apparently healthy individuals are typically between 0.9 and 1.5 
mmol/L, however can reach up to 40mmol/L in cancer survivors with evidence of 
metastasis (Tesch et al., 1978; Walenta et al., 1997). Blood is continuously flowing 
through the human body delivering and collecting metabolites to and from tissues to 
promote a homeostatic environment. Upon the initiation of exercise, skeletal muscle 
contraction mediated blood flow increases the rate at which blood flows throughout the 
vasculature, enabling the vasculature to deliver and collect metabolites at higher rates to 
meet the energy demands of different tissue (Jorfeldt & Wahren, 1971; Lash, 1996). It is 
plausible to believe that at least a percentage of lactate that is being produced by tumors 
is extruded into the vasculature and can be measured. Furthermore, upon the onset of 
increased exercise-mediated flow, it is plausible to believe that nutrients typically 
directed to tumors can be redirected to working skeletal muscle and other tissues during 




This application of exercise to reduced rates of flow to a tumor may perhaps reduce the 
rate at which tumors can grow, produce lactate, and stimulate angiogenesis, or even 
starve the tumor itself.  
Conclusion 
Tumors, even in the presence of adequate oxygen saturation, prefer anaerobically 
glycolytic methods of energy production and the subsequent overproduction of lactate. It 
has been discovered that three genes, HIF-1α, c-Myc, and p53, are largely responsible for 
the upregulation of glycolytic intermediates including lactate dehydrogenase enzymes, 
glucose transport proteins, and monocarboxylate transport proteins. Current research in 
cancer metabolism has effectively characterized the pattern in which carcinogenic cells 
upregulate said factors, leading to high volumes of glucose entry into the tumor and the 
subsequent overproduction, accumulation, and disposal of lactate without its oxidation to 
pyruvate for further oxidative processes.  
Lactate continues to be associated with signaling mechanisms for the upregulation 
of glucose transporters and MCT’s necessary for improved lactate handling. As increased 
rates of lactate exit tissue environments, decreased pH levels stimulate acidosis-induced 
angiogenesis. This increase in vasculature provides the tumor with more nutrients for 
growth and proliferation, allowing the tumor to continue along a vicious cycle of 
glycolysis and lactate production. 
High levels of lactate concentrations in cancer survivors is associated with 
increased risks of metastasis and cancer aggressiveness. It is well established that 
exercise can attenuate the production of lactate through the upregulation of transport 




which are typically down regulated in cancer survivors. Through exercise mediated flow 
and metabolic adaptations to exercise, it may be possible to effectively redirect 
metabolites away from the tumor microenvironment and towards metabolic processes of 
active tissue during exercise.  
Very few studies have investigated lactate production in cancer survivors and no 
studies have monitored lactate production before and after an exercise-intervention. The 
purpose of this study was to assess the effect of exercise training on lactate handling in 
cancer survivors, and further, to assess any differences between those actively receiving 
cancer therapies and those not. This study provides much needed knowledge about the 
effects of an exercise intervention on lactate production, accumulation, and disposal in 








EFFECTS OF EXERCISE TRAINING ON THE BLOOD 
LACTATE RESPONSE TO ACUTE EXERCISE 
IN CANCER SURVIVORS  
 
Abstract 
Cancer metabolism, emerging as a clear biomarker of cancer, is characterized by 
increased levels of lactate production, even in the presence of adequate oxygen 
saturation. This is a preliminary investigation on blood lactate response in cancer 
survivors actively undergoing cancer treatment (active) vs cancer survivors not currently 
going through cancer treatment (inactive). Exercise has been shown to regulate lactate 
production, accumulation, and disposal in diseased populations, however little is known 
about the exercise effects on lactate handling in a cancer population. Purpose: To 
determine the effect of a 12-week exercise intervention on lactate parameters in cancer 
survivors in treatment versus out of treatment during an exercise bout to volitional 
fatigue. Methods: Twenty-one cancer survivors were recruited for a 12-week exercise-
based oncology rehabilitation intervention (active n = 7; inactive n = 14). Prior to the 12-
week exercise intervention, cardiovascular endurance was assessed using a progressive 
treadmill protocol to volitional fatigue. Blood lactate accumulation (BLA) was quantified 
every two minutes during the exercise assessment via finger stick and compared to 
measures taken during a reassessment treadmill protocol 12 weeks later. Results: 
Resting, Peak, and METS at OBLA values of active and inactive cancer survivors before 




Resting, Peak, and METS at OBLA values between active and inactive cancer survivors 
before and after an exercise intervention were not significantly different (P>0.05). 
However, METS at OBLA in both active and inactive survivors were significantly 
different before and after a 12-week exercise intervention (P<0.05). Conclusions: Lack 
of significance in these findings may indicate similar responses of lactate handling to 
exercise training in both cancer groups. This finding is supported by a significant increase 
in METS at OBLA of the total subject population before and after the exercise 
intervention suggesting an improved ability to buffer lactate at higher intensities during 
an acute exercise bout to fatigue. Keywords: BLOOD LACTATE ACCUMULATION, 
CANCER SURVIVORS, EXERCISE, METABOLIC EQUIVALENTS, ONSET OF 









Cancer is defined by abnormal, uncontrolled cell division and its respective 
spread to other parts of the body through the blood and lymph systems (National Program 
of Cancer Registries , 2018). As diagnoses of cancer increase, cancer-mediated 
dysfunction in metabolic behavior and related lactate production continues to emerge as a 
clear characteristic of cancer; a step along the road of carcinogenesis identified amongst a 
majority of cancers (Cairns et al., 2011). Normal cells proliferate under a series of 
heavily regulated pathways and control mechanisms. When normal cells are affected by 
mutations caused by environmental or hereditary influences, they are no longer governed 
by genetic regulation but instead divide and proliferate rapidly and abnormally. In order 
to sustain high rates of cell proliferation and division, cancerous cells fundamentally 
change their metabolic characteristics in favor of glycolytic pathways even when oxygen 
is abundant. A byproduct of high rates of glycolytic processes results in the subsequent 
production of lactate, however this accumulation of lactate is not buffered by successive 
oxidation to pyruvate in tumors, according to German physiologist Otto Warburg, as it is 
in apparently healthy cells (Warburg et al., 1927). Instead, through a series of upregulated 
glycolytic intermediates and transport proteins, lactate is extruded from the tumor 
microenvironment and continues to act as a stimulatory mechanism resulting in increased 
rates of angiogenesis via acidosis-induced angiogenesis (Sonveaux et al., 2012). 
Respective oncogenic and tumor-suppressor gene gain of function and loss of function 




accumulation, and disposal are associated with the subsequent development of metastasis 
and cancer aggressiveness (Kunkel et al., 2003).  
 Lactic acid, a lactate molecule paired with a hydrogen proton, is produced in 
excess during prolonged moderate-to-high intensity exercise. As rates of ATP production 
via oxidative phosphorylation are unable to meet the energy demand of increasing 
exercise intensity, the human body efficiently switches to glycolytic-based energy 
production, yielding ATP far quicker than that of oxidative phosphorylation. In other 
words, as catabolic demands exceed the rate of maximal oxygen consumption, energy 
metabolism switches from oxidative phosphorylation to glycolytic methods of energy 
production. Physiologists have quantified this metabolic switch during maximal exercise 
and defined it as an individual’s Lactate or Anaerobic Threshold, where rates of oxygen 
consumption and utilization cannot meet the demand for ATP production resulting in the 
successive overproduction of lactate and decreased pH levels.  
 As we know that lactate is an important metabolic indicator for cancer 
metabolism as well as evidence of metastasis and tumor aggressiveness, determining the 
response of blood lactate during progressive exercise bouts in a cancer population may 
provide some insight into the effects of exercise on cancer development, progression, and 
metastasis. Both endurance and resistance exercise modalities have been shown to aid in 
gene regulation as it relates to lactate handling. The purpose of this study was to 
investigate the blood lactate accumulation response to a progressive exercise bout to 
volitional fatigue before and after a 12-week exercise-based oncology rehabilitation 
intervention between cancer survivors currently undergoing treatment and cancer 







 The purpose of this study was to investigate blood lactate accumulation response 
to a progressive exercise bout to volitional fatigue before and after a 12-week exercise-
based oncology rehabilitation intervention between cancer survivors currently undergoing 
treatment and cancer survivors not currently undergoing treatment. Cancer survivors 
were divided into two groups: those actively receiving chemotherapy or radiation and 
those not currently receiving chemotherapy or radiation. Participants were screened 
through an inclusive screening process of physiological and psychological parameters, 
including blood lactate accumulation (BLA) during a progressive exercise bout to 
volitional fatigue. BLA response in mmol/L was measured every two minutes during the 
UNCCRI Treadmill Protocol, a graded exercise assessment, using a Nova Biomedical 
Lactate Plus Meter along with Lactate Plus Meter test strips and safety lancets. BLA 
response was measured during the initial assessment and again after a 12-week exercise 
intervention, and the results were compared.   
Subjects 
Twenty-one cancer survivors were referred by their oncologists or primary care 
physician and recruited to participate in a 12-week exercise-based rehabilitation 
intervention study at the University of Northern Colorado Cancer Rehabilitation Institute 
(UNCCRI). Cancer survivors recruited for this study underwent a comprehensive 
screening process, assessing pertinent cancer related information and treatment history, 




physical activity levels. Participants were divided into two groups: active cancer 
survivors, or survivors currently undergoing chemotherapy or radiation, (n=7) and non-
active cancer survivors, survivors not currently undergoing chemotherapy or radiation 
(n=14). All participants in this study were volunteers through the University of Northern 
Colorado Cancer Rehabilitation Institute (UNCCRI) at the University of Northern 
Colorado located in Greeley, CO. Inclusion criteria for this study included both male and 
female cancer survivors with or without metastasis regardless of treatment status and 
physical activity level.  
This human subjects study was reviewed and approved by the Institutional 
Review Board at the University of Northern Colorado. Before agreeing to this study, 
participants were given a UNCCRI research participation informed consent form to 
review and sign, were informed of the specific study and all risks associated with the 
study, and verbally consented to volunteering for the study. All participants were cleared 
by their oncologist and/or primary care physician to participate in an exercise-based 
rehabilitation program.   
University of Northern Colorado  
Cancer Rehabilitation Institute  
12 Week Exercise Based  
Rehabilitation 
Prior to the study, all participants performed an initial assessment supervised by 
staff exercise physiologists. This assessment quantified pulmonary function, muscular 
strength, and cardiovascular fitness. Pulmonary function was measured by staff Cancer 
Exercise Specialists (CES) and assessed using a MIR Spirolab III pulmonary function 
device (MIR Group USA Head Office, New Berlin, Wisconsin) to measure Forced Vital 




series of estimated 1 repetition maximum tests in both lower and upper extremity 
exercises, was measured by staff CES and assessed utilizing Selectorized Cybex Eagle 
strength training equipment (Owatanna, Minnesota). Cardiovascular endurance was 
assessed utilizing the UNCCRI Treadmill Protocol, a valid and reliable graded Vo2peak 
exercise assessment where speed and/or grade are increased every minute, on a treadmill 
(Shackelford, Brown, Peterson, Schaffer, & Hayward, (in press)). Lactate accumulation 
was measured during the UNCCRI treadmill protocol using a Nova Biomedical Lactate 
Plus Meter along with Lactate Plus Test Strips and Safety Lancets (Waltham, 
Massachusetts).  
Upon completion of the initial assessment, CES use the comprised data to 
generate an individualized 12-week exercise-based oncology rehabilitation intervention 
consisting of 20 minutes of cardiovascular endurance exercise, 30 minutes of resistance 
training, and 10 minutes of balance and flexibility training. The intervention follows 
guidelines defined by the Phase Training protocol for oncology-based exercise 
rehabilitation, developed within at UNCCRI (Brown JM, Shackelford DYK, Cress M, 
Hayward R.  Evaluation of an Exercise-Based Phase Program as Part of a Standard Care 
Model for Cancer Survivors.  Translational Journal of the American College of Sports 
Medicine (in press)). Active survivors, defined here as those currently undergoing 
chemotherapy or radiation, entered the phase training protocol in Phase 1, whereas 
inactive survivors, defined here as those not currently undergoing chemotherapy or 
radiation, have recently received surgical intervention, or hormonal/immunotherapy, 
entered the phase training protocol in Phase 2. The phase training protocol largely refers 




week exercise intervention. Cardiovascular intensities are based on a percentage of heart 
rate reserve (HRR), which is calculated using the Karvonen formula. Phase 1 participants 
exercise at low to moderate intensity, or 30-45% of the individual’s HRR according to 
ACSM guidelines, in order to efficiently preserve health status and combat toxicities of 
treatment. Phase 2 participants are eligible to exercise at a moderate intensity, defined as 
40-60% of their individual HRR according to ACSM guidelines, with the purpose of 
building functional foundation of movement structured around the individual while also 
eliciting chronic adaptations to exercise (American, 2013). After every 12 weeks, 
participants are reassessed through all physiological parameters assessed during the initial 
assessment and are given a new 12-week exercise progression through their next 
appropriate phase.  
Lactate Measurement 
 Lactate samples were collected before, after, and throughout the UNCCRI 
treadmill protocol during a participant’s initial assessment and at their respective 
reassessment 12 weeks thereafter. Lactate samples were collected on the ring finger of 
the right hand unless lymph nodes have been removed from the right arm. Regardless of 
the presence of lymphedema, if lymph nodes had been removed from the right arm, 
lactate samples were collected from the ring finger of the left hand. Participants were 
given a rechargeable hand warmer to stimulate increased blood flow to the fingertips in 
order to prevent sticking the finger several times. After the hand was warmed for two to 
three minutes, the hand warmer was turned off and a sterile Curad Alcohol Prep Pad 
(Mundelein, Illinois) was used to wipe and clean the surface of the finger. After waiting 




Biomedical Lactate Plus Safety Lancet (Waltham, Massachusetts). With both thumbs, the 
researcher then applied upward pressure from the bottom of the finger to the fingertip to 
allow a droplet of blood to form. The droplet of blood was then wiped away with a sterile 
Covidien Curity 2” x 2” gauze pad (Mansfield, Massachusetts) in order to wipe away any 
residual alcohol left on the finger, which may skew the lactate measure or cause an error. 
After a second droplet of blood was formed, the droplet was collected and analyzed for 
15 seconds via a Lactate Plus Meter and Lactate Plus Test Strips (Mansfield, 
Massachusetts) and recorded on the “Resting Measure” area of a UNCCRI lactate 
accumulation protocol chart in mmol/L. Upon collecting samples, researchers held the 
analyzer slightly horizontal as to prevent blood from touching the bottom surface of 
Lactate Plus Test Strip, as this may result in an error. Prior to the initiation of the 
UNCCRI treadmill protocol, participants were asked to recall a food log of the present 
day and were instructed on proper procedure for lactate sampling during an exercise 
assessment to volitional fatigue; participants were instructed to, while walking or 
running, place their hand palm side up on the handrail of the treadmill while the 
researcher collected a droplet of blood.  
Researchers collected samples approximately every two minutes utilizing the 
same upward-pressure technique mentioned above. Lactate accumulation measures were 
recorded on the same protocol chart developed by UNCCRI along with a Rating of 
Perceived Exertion (RPE), which was quantified every three minutes by the participant. 
So as not to impede with the efficacy of the treadmill protocol and its estimation of 
Vo2peak, lactate accumulation measurements were halted at an RPE of approximately 6 or 




assessment and then again after an individualized cool down phase. After a final cool-
down, lactate accumulation measurement was taken, another Curad alcohol prep pad was 
used to wipe away residual blood on the finger and a bandage was applied to prevent 
blood from contacting any external surfaces. Lactate Plus Saftey Lancets are disposed of 
in a biohazard sharps only container. The blood lactate accumulation data collection form 
appears in Figure 1. 
 
 







 Metabolic Equivalents (METS) were used to evaluate changes in lactate 
parameters and lactate handling during a progressive exercise bout to volitional fatigue 
before and after a 12-week exercise-based oncology rehabilitation intervention. UNCCRI 
has compiled an assessment manual containing normative values for all physiological and 
psychological parameters assessed throughout the exercise intervention to better identify 
meaningful adaptations to exercise training. METS are used to estimate the energy 
expenditure of many different physical activities, where one MET is equal to 3.5 
milliliters of oxygen consumed per kilogram of bodyweight per minute. METS were 
calculated at each stage of the UNCCRI treadmill protocol for both walking and running 
aspects of the assessment, according to the UNCCRI assessment manual. OBLA is 
defined as the intensity of exercise at which lactate begins to accumulate exponentially 
and was quantified objectively. If OBLA values ≥4.0 mmol/L, were not obvious at a 
particular stage of the UNCCRI treadmill protocol, either the stage of termination or the 
stage before were utilized to calculate METS at OBLA.  
Statistical Analysis 
 Means and standard deviations were calculated for Resting, Peak, and METS at 
OBLA for the groups combined as well as active and inactive cancer survivors before and 
after a 12-week oncology-based exercise rehabilitation intervention. A paired two-tailed 
t-test analysis was used to test for significance between variables before and after a 12-
week oncology-based exercise rehabilitation intervention. An alpha level of less than 






 Table 1 summarizes values before and after a 12-week exercise-based oncology 
rehabilitation intervention. Twenty-one participants comprised of 12 females and 9 males 
volunteered for this study. Of the 21 total participants, 7 were classified as active cancer 
survivors: those actively receiving chemotherapy or radiation treatment. Fourteen were 
classified as inactive cancer survivors: those not actively receiving chemotherapy or 
radiation treatment. All participants were able to safely complete all protocols described 
for the present study without any adverse events.  
Table 1 
Subject Demographics 
 Active Inactive 
Total n 7 14 
Gender   
     Females 3 9 
     Males 4 5 
Age   
     ≥60 5 5 
     ≤60 2 9 
Treatment Types   
     Chemotherapy 4 5 
     Radiation 1 4 
     Both 2 2 
     None - 3 
Stage (pre) 7.57±2.92 8.86±2.26 
Stage (post) 9.57±2.66 9.71±2.76 
Resting (mmol/L) (pre) 2.44±0.92 1.84±0.74 
Peak (mmol/L) (pre) 6.2±2.67 6.26±2.91 
Resting (mmol/L) (post) 1.98±0.62 1.62±0.66 
Peak (mmol/L) (post) 7.96±1.75 7.88±3.79 
METS at OBLA (ml/kg/min) (pre) 5.96±1.39 6.77±1.59 
METS at OBLA (ml/kg/min) (post) 7.36±1.80 7.73±1.44 
METS = Metabolic Equivalents; OBLA = Onset of Blood Lactate Accumulation. Data for 
Pre- and Post- measurements are displayed as Mean ± SD. Significance levels for Pre- to 
Post- measurements are displayed in Post- data sets for Active and Inactive survivors 





Resting Lactate Accumulation 
Mean resting lactate accumulation (RLA) for active cancer survivors decreased 
from 2.44 ± 0.92 to 1.98 ± 0.62 mmol/L (p = 0.33) after a 12-week exercise intervention 
(Figure 1). Mean RLA for inactive cancer survivors also decreased from 1.84 ± 
0.74mmol/L to 1.62 ± 0.66mmol/L (p = 0.44) after a 12-week exercise-based oncology 
rehabilitation intervention (Figure 2). RLA between active and inactive cancer survivors 
lacked statistical significance before and after an exercise intervention (P = 0.19, P = 0.26 
respectively). 
 
Figure 2: Resting Lactate Accumulation in Cancer Survivors 
Pre (Left) and Post (Right) display mean resting lactate accumulation concentrations 
(mmol/L) with standard deviations in active (n=7) and inactive (n=14) cancer survivors 
before and after a 12-week exercise-based oncology rehabilitation intervention. No 


































Peak Lactate Accumulation 
Mean peak lactate accumulation (PLA) for active cancer survivors increased from 
6.20 ± 2.67mmol/L to 7.96 ± 1.75mmol/L (p = 0.21) after a 12-week exercise-based 
oncology rehabilitation intervention (Figure 3). Mean PLA for inactive cancer survivors 
also increased from 6.26 ± 2.91mmol/L to 7.88 ± 3.79mmol/L (p = 0.28) after a 12-week 
exercise-based oncology rehabilitation intervention (Figure 4). PLA between active and 
inactive cancer survivors lacked statistical significance before and after an exercise 
intervention (P = 0.97, P = 0.84 respectively). 
 
Figure 3: Peak Lactate Accumulation in Cancer Survivors 
Pre (Left) and Post (Right) display mean peak lactate accumulation concentrations 
(mmol/L) with standard deviations in active (n=7) and inactive (n=14) cancer survivors 
before and after a 12-week exercise-based oncology rehabilitation intervention. No 
































Metabolic Equivalents at Onset of Blood Lactate Accumulation 
Mean metabolic equivalent at the stage of OBLA (METOBLA) of active cancer 
survivors increased from 5.96 ± 1.39 O2/kg/min to 7.36 ± 1.80 O2/kg/min (p = 0.14) after 
a 12-week exercise-based oncology rehabilitation intervention (Figure 5). Mean 
METOBLA of inactive cancer survivors increased from 6.77 ±1.59 O2/kg/min to 7.73 ± 
1.44 O2/kg/min (p = 0.19) after a 12-week exercise-based oncology rehabilitation 
intervention (Figure 6). RLA between active and inactive cancer survivors lacked 
significance before and after an exercise intervention (p = 0.48, p = 0.77 respectively). 
However, when comparing the effects of a 12-week exercise intervention on METOBLA 
in the overall sample size (n=21), METOBLA increased from 6.29 ± 1.58 to 7.51 ± 1.74 
(p = 0.04) (Figure 7). Lack of significance in active and inactive cancer survivor groups 
individually may be due to insufficient sample size.  
Figure 4: METS at OBLA in Cancer Survivors 
Pre (Left) and Post (Right) display mean Metabolic Equivalents (METS) (ml/kg/min) at 
Onset of Blood Lactate (OBLA) with standard deviations in active (n=7) and inactive 
(n=14) cancer survivors before and after a 12-week exercise-based oncology 



































Figure 5: METS at OBLA in Cancer Survivors 
METS (mL/kg/min) at OBLA for total subject population before and after a 12-week 
exercise-based oncology rehabilitation intervention. A two-tailed T-Test was used to test 
for evidence of significant differences. *P<0.05 vs. POST.  
 
Stage Completion 
Mean stage completion of active cancer survivors increased from 7.57 ± 2.92 to 
9.57 ± 2.66 stages (p = 0.24) after a 12-week exercise-based oncology rehabilitation 
intervention (Figure 8). Mean stage completion of inactive cancer survivors increased 
from 8.86 ± 2.26 to 9.71 ± 2.76 stages (p = 0.39) after a 12-week exercise-based 













































Figure 6: Stage Completion in Cancer Survivors 
Pre (Left) and Post (Right) display mean stage completion with standard deviations in 
active (n=7) and inactive (n=14) cancer survivors before and after a 12-week exercise-





Studies on blood lactate parameters during exercise in a cancer population are 
lacking. As our understanding of lactate as an important precursor for tumorigenesis and 
a biomarker for evidence of metastasis and increased aggressiveness of cancer, it 
becomes all the more important to elucidate the mechanisms of how lactate handling can 
be affected in a cancer population. It is largely understood that exercise improves lactate 
handling in apparently healthy models, however the effects of exercise on lactate 
handling in a cancer population remains unclear. 
Numerous studies indicate dysfunction and dysregulation in lactate handling in 
cancer survivors but how this can be attenuated through exercise is still unknown. 












Average Stage Completion in Active and Inactive Cancer 






improvements in cardiovascular fitness and muscular strength, along with decreased 
fatigue and muscle wasting when compared to other diseased populations. No 
comparisons of blood lactate accumulation in cancer survivors and other populations 
exist, however. The present study demonstrates no significant differences in blood lactate 
accumulation between active and inactive before and after a 12-week exercise-based 
oncology rehabilitation intervention. A 12-week exercise-intervention for cancer 
survivors was able to improve buffering of lactate accumulation and subsequent exercise 
tolerance with increasing intensity of exercise, implying a regulatory approach to lactate 
production in cancer survivors. All participants in this study were able to safely complete 
this exercise protocol without any adverse effects. 
Blood Lactate Handling 
In the present study, changes in blood lactate accumulation (BLA) were 
quantified by comparing resting, peak, and METs at OBLA values between active and 
inactive cancer survivors. A 12-week oncology-based exercise rehabilitation intervention 
resulted in a lack of significant differences PRE/POST in resting (P = 0.19, 0.26), peak (P 
= 0.97, 0.84), and MET at OBLA (P = 0.48, P = 0.77) blood lactate accumulation levels 
between active and inactive cancer survivors respectively. However, significance in 
METS at OBLA was found before and after an exercise intervention between the entire 
population sample (P = 0.04), implying that the lack of significance between active and 
inactive populations could be due to an insufficient sample size. It is also notable that the 
lack of significance between active and inactive survivors could imply that groups may 
react to an exercise intervention in a similar fashion. This would indicate that typical 




may not affect the way cancer survivors regulate lactate production, accumulation, and 
disposal upon the intervention of an exercise-based oncology rehabilitation program. A 
study conducted by Brizel et al., (2001) found that blood lactate concentrations of cancer 
survivors were up to 40% higher than that of an apparently healthy population.  For 
apparently healthy individuals, blood lactate is normally 1-2 mmol/L at rest.  In the 
present study, only the Active Survivors before (PRE) participating in the exercise 
intervention had a mean resting lactate value in excess of the normal range.  This 
supports the notion that cancer may increase resting lactate since these individuals were 
undergoing treatments for active cancers.  Whether high intracellular lactate levels of 
cancer cells translates to increased blood lactate was not determined in this study. Future 
studies should uncover the relationship between tumor lactate concentrations and blood 
lactate concentrations. Future studies may also benefit from deciphering the effects of an 
exercise intervention on resting lactate levels with a larger population size, as higher 
resting lactate levels are associated with cancer metastasis and poor prognosis. 
METS are widely used as a clinical tool to estimate the energy expenditure of 
many different physical activities, where one MET is equal to 3.5 milliliters of oxygen 
consumed per kilogram of bodyweight per minute.  A question posed here was related to 
whether an exercise intervention would allow cancer survivors to reach OBLA at higher a 
MET value after a 12-week exercise intervention. According to the study at hand, the 
cancer survivors that participated in this study did reach OBLA at significantly higher 
METS after a 12-week exercise intervention suggesting their ability to perform and 
effectively utilize oxygen to recycle lactate at higher intensities of exercise. OBLA levels, 




METS, treadmill protocol indicating improved exercise tolerance and lactate 
accumulation buffering as well as similar responses to exercise when compared to 
apparently healthy populations. Similar responses in active and inactive cancer survivors 
lacked significance, which may be due to an insufficient population size.  
With a larger sample size, it is hypothesized that exercise would decrease resting 
lactate accumulation concentrations, increase peak lactate accumulation concentrations, 
and increase METS at OBLA, as it is seen in apparently healthy populations. These 
effects would indicate improved lactate handling in cancer survivors.  
Potential Mechanisms of Lactate Handling  
in Cancer Survivors 
 The introduction of oxidative stress and chronic aerobic exercise training has been 
shown to lead to the upregulation of oxidative enzymes necessary for glycolytic 
catabolism and the subsequent utilization of glycolytic metabolites for oxidative 
phosphorylation. Endurance exercise-induced metabolic adaptations and/or resistance 
training-induced upregulation of MCT proteins facilitates improved lactate handling. 
Finding the difference between endurance and resistance exercise modalities on blood 
lactate accumulation in cancer survivors or pairing these exercise modalities together 
may maximize the potential to regulate lactate handling in cancer survivors thereby 
plausibly limiting the degree of acidosis induced angiogenesis and subsequent tumor 
metastasis and aggressiveness.  
 Recent studies indicate differences in cancer cell protein expression and metabolic 
behavior depending on the distance of cancer cells from the tumor vasculature. Cancer 
cells located farther from the tumor vasculature are inherently hypoxic and therefore 




lactate production and extrusion into the tumor microenvironment. Cancer cells closer to 
the tumor vasculature are inherently oxidative, expressing high levels of LDHB and 
MCT1 proteins, collectively leading to a high affinity for lactate uptake and conversion to 
pyruvate for oxidative phosphorylation. This metabolic symbiosis is referred to as the 
“reverse Warburg effect,” and postulates how metabolically self-sufficient tumors can be 
(Doherty & Cleveland, 2013; Whitaker-Menezes et al., 2011). It is speculated that 
catabolites and oxidative stress extruded into vasculature through exercise may starve 
tumors of nutrient and hypoxic factors (HIF-1𝛼), resulting in decreased glycolytic 
intermediates and decreased lactate production as well as subsequent acidosis mediated 
angiogenesis.  
 In addition to exercise-mediated responses in improved lactate handling, exercise 
has also been noted to assist in proto-oncogenic and tumor-suppressor gene regulation. 
With far more literature justifying an effect of endurance training on carcinogenic gene 
regulation, it is plausible to imply that there are effects of exercise training on the 
regulation of glycolytic enzymes under- or overregulated by carcinogenic gene 
dysfunction either by exercise mediated gene regulation/repair or glycolytic protein 
(Sharafi & Rahimi, 2012). Furthermore, exercise mediated gene and glycolytic protein 
regulation would evidently shunt cancer mediated lactagenesis and improve lactate 
handling in cancer survivors (van Ginkel et al., 2016).   
Limitations 
 Multiple studies describe a dysregulation in tumor intracellular lactate 
concentrations, however few address its relationship with blood lactate accumulation. As 




lactate produced by tumors is extruded into the bloodstream. A limitation of this study is 
that tumor lactate concentrations were not quantified. Another limitation of this study 
includes the use of the Lactate Plus System, which is not FDA cleared for performing 
lactate measurements on persons for a medical intervention. The Lactate Plus System is 
intended for sports training and conditioning only. Furthermore, lactate concentrations 
were measured every two minutes during the treadmill protocol assessment, but due to 
the extensive monitoring of vitals during exercise testing, lactate concentrations were not 
measured every two minutes exactly. When pertaining to those severely compromised by 
their cancer and cancer treatment, some participants did not reach OBLA during the 
protocol, or OBLA was not obviously defined throughout their assessment. As such, if 
OBLA was not obviously measured, OBLA was assumed to be the concentration 
measured at the stage of or the stage before termination (OBLA met a ≥4.0mmol/L 
concentration criteria). In addition, the 12-week exercise intervention included both 
endurance and resistance training. Future studies should determine a difference in lactate 
handling, if any, between resistance training and endurance training in a cancer model. 
 Finally, the present study included participants of multiple cancer diagnoses and 
stages. As a result, the outcomes of this study may not apply to all cancer diagnoses and 
stages, since cancers can differ in both genotype and phenotype. Future studies should be 
conducted on homogeneous populations of cancer diagnoses and/or stages to collect 
accurate information on the production, accumulation, and disposal of lactate at rest and 









Tumor cells are characterized as cells that undergo high rates of glycolysis 
excessive lactate formation, even in the presence of adequate oxygen (Warburg et al., 
1927). It is well known that due to the collaborative dysfunction of proto-oncogenes and 
tumor-suppressor genes there is an upregulation of glycolytic enzymes and transport 
proteins that facilitate the catabolism of glucose and its subsequent excessive lactate 
production. Cancer survivors display dysregulation in how lactate is produced, 
accumulated, and disposed of and these notable dysregulations have been associated with 
increased cancer aggressiveness (Kunkel et al., 2003).  
Blood lactate concentrations in cancer survivors have been found to be up to 40% 
higher than that of an apparently healthy population and lactate itself has been referred to 
as a “lactormone;” a lactate-mediated cell signaling molecule, due to its involvement in 
the upregulation of transport proteins and growth factors (Brizel et al., 2001; Brooks, 
2009). Furthermore, current research in physiology emphasizes the effects of exercise on 
improved lactate handling in vivo largely due to the increased transcription of glycolytic, 
mitochondrial, and transport proteins. 
However, research literature on blood lactate parameters during exercise in a 
cancer population is lacking. As lactate becomes an important precursor for 




of the cancer, it becomes all the more important to understand the mechanisms of how 
dysfunction of lactate handling can be attenuated in a cancer population.  
Exercise interventions in cancer populations have found similar significant 
improvements in cardiovascular fitness, muscular strength and decreased muscle wasting, 
and other physiological parameters when compared to that of apparently healthy and 
other diseased populations. No comparisons of blood lactate accumulation in cancer 
survivors and other populations exist, however. The present study aimed to demonstrate 
differences in blood lactate accumulation between active and inactive cancer survivors 
before and after a 12-week exercise-based oncology rehabilitation intervention. A 12-
week exercise-intervention for cancer survivors was able to improve exercise tolerance 
and subsequent buffering of lactate accumulation with increasing intensity of exercise, 
implying a regulatory approach to lactate production in cancer survivors. All participants 
in this study were able to safely complete this exercise protocol without any adverse 
effects. 
Blood Lactate Handling 
In the present study, changes in blood lactate accumulation (BLA) were 
quantified by comparing resting, peak, and Metabolic Equivalents at the Onset of Blood 
Lactate Accumulation (MET at OBLA) values between active and inactive cancer 
survivors. A 12-week oncology-based exercise rehabilitation did not significantly change 
blood lactate at rest (P = 0.19, 0.26), peak exercise (P = 0.97, 0.84), and MET at OBLA 
(P = 0.48, P = 0.77) between active and inactive cancer survivors respectively. 
Furthermore, significance in METS at OBLA was found before and after an exercise 




significance between active and inactive populations could be due to an insufficient 
sample size. It is also notable that the lack of significance between active and inactive 
survivors could imply that groups may react to an exercise intervention in a similar 
fashion. This would indicate that typical cancer treatment may not play a role in lactate 
production in cancer survivors and further, may not affect the way cancer survivors 
regulate lactate production, accumulation, and disposal upon the intervention of an 
exercise-based oncology rehabilitation program. A study conducted by Brizel et al., 
(2001) found that blood lactate concentrations of cancer survivors were up to 40% higher 
than that of an apparently healthy population. Future studies may benefit from 
deciphering the effects of an exercise intervention on resting lactate levels with a larger 
population size, as higher resting lactate levels are associated with cancer metastasis and 
poor prognosis. 
METS equal the product of the amount of oxygen consumed/utilized multiplied 
by the resting value (3.5 ml/kg/min) and so a question to help elaborate on improved 
lactate handling during an exercise intervention in cancer survivors is, “did cancer 
survivors reach OBLA at higher METS after a 12-week exercise intervention?” 
According to the study at hand, the 21 cancer survivors that participated in this study did 
significantly reach OBLA at higher METS after a 12-week exercise intervention 
implying their bodies are capable of performing and effectively utilizing oxygen to 
recycle lactate at higher intensities of exercise. OBLA levels, when comparing pre- to 
post-exercise intervention, were lower at similar stages and METS, of the UNCCRI 
treadmill protocol indicating improved exercise tolerance and lactate accumulation 




populations. Similar responses in active and inactive cancer survivors lacked 
significance, which may be due to an insufficient population size.  
With a larger sample size, it is hypothesized that exercise would decrease resting 
lactate accumulation concentrations, increase peak lactate accumulation concentrations, 
and increase METS at OBLA, as it is seen in apparently healthy populations. These 
effects would indicate improved lactate handling in cancer survivors.  
Potential Mechanisms of Lactate Handling  
in Cancer Survivors 
 Current literature has shown exercise mediated regulations of proto-oncogenes 
and tumor-suppressor genes particular to lactate production in cancer survivors. With far 
more literature proposing endurance training versus resistance training-mediated 
regulation of these genes, included are HIF-1𝛼, c-Myc, and p53, which when susceptible 
to dysfunction collaborate to promote the upregulation of glycolytic mechanisms. As a 
result, tumor microenvironments are characterized as high in glucose influx and high in 
lactate production, accumulation, and disposal. Skeletal muscle contraction induces 
increased rates of flow throughout the vasculature. Upon the initiation of exercise, 
increased rates of skeletal muscle contraction follows, as does skeletal muscle contraction 
mediated blood flow in the attempt to adequately supply nutrient and eliminate waste to 
and from metabolizing tissue as is seen in apparently healthy populations (Jorfeldt & 
Wahren, 1971; Lash, 1996). Theoretically, through exercise mediated increases in blood 
flow, it is hypothesized that exercise may redirect the nutrient typically being perfused to 
a tumor towards working tissues during exercise. Additionally, it is plausible to assume 




microenvironment as well, preventing acidosis induced angiogenesis responses to lactate 
production.  
 Upon higher intensities of exercise, the body is introduced to oxidative stress, or 
the inability of tissues to eradicate reactive oxygen species efficiently. The introduction 
of oxidative stress and chronic aerobic exercise training has been shown to lead to the 
upregulation of oxidative enzymes necessary for glycolytic catabolism and the 
subsequent utilization of glycolytic metabolites for oxidative phosphorylation. With an 
increase in flow, there is an increase in oxidative stress introduced to a tumor 
microenvironment, which is heavily glycolytic and unable to attenuate to the reactive 
oxygen species accumulating throughout the vasculature. Miyata, Matsuo, Sagara, Ohba, 
Ohyama, & Sakai (2017), have found that introducing reactive oxygen species to the 
tumor microenvironment can induce apoptosis, or programmed cell death.  
 In addition to flow-mediated applications of lactate handling in cancer 
populations, there is evidence of improved lactate handling with both endurance and 
resistance-based exercise modalities. Through the upregulation of MCT and glucose 
transport proteins, as well as glycolytic intermediates necessary for oxidative 
phosphorylation, individuals can tolerate exercise at higher intensities through the 
utilization of oxidative energy-yielding mechanisms and subsequent lactate buffering. 
This study hypothesized that after a 12-week exercise intervention, a cancer survivor 
would be able to handle lactate production, accumulation, and disposal more efficiently. 
However, it is unclear whether these exercise-mediated effects in lactate handling were 
due to endurance training, resistance training, or a combination of both. Finding the 




accumulation in cancer survivors or pairing these exercise modalities together may 
maximize the potential to regulate lactate handling in cancer survivors thereby plausibly 
limiting the degree of acidosis induced angiogenesis and subsequent tumor metastasis 
and aggressiveness.  
 Recent studies indicate differences in cancer cell protein expression and metabolic 
behavior depending on the distance of cancer cells from the tumor vasculature. Cancer 
cells located farther from the tumor vasculature are inherently hypoxic and therefore 
highly glycolytic, expressing high levels of LDHA and MCT4 proteins thus facilitating 
lactate production and extrusion into the tumor microenvironment. Cancer cells closer to 
the tumor vasculature are inherently oxidative, expressing high levels of LDHB and 
MCT1 proteins, collectively leading to a high affinity for lactate uptake and conversion to 
pyruvate for oxidative phosphorylation. This metabolic symbiosis is referred to as the 
“reverse Warburg effect,” and postulates how metabolically self-sufficient tumors can be 
(Doherty & Cleveland, 2013) (Whitaker-Menezes et al., 2011). It is speculated that 
catabolites and oxidative stress extruded into vasculature through exercise-mediated 
increases in flow may starve tumors of nutrient and hypoxic factors (HIF-1𝛼), resulting 
in decreased glycolytic intermediates and decreased lactate production as well as 
subsequent reactive oxygen species mediated apoptosis.   
Limitations 
Multiple studies describe a dysregulation in tumor intracellular lactate 
concentrations, however few address its relationship with blood lactate accumulation. As 
MCT proteins are upregulated in cancer populations, it is assumed that some portion of 




that tumor lactate concentrations were not quantified. Another limitation of this study 
includes the use of the Lactate Plus System, which is not FDA cleared for performing 
lactate measurements on persons for a medical intervention. The Lactate Plus System is 
intended for sports training and conditioning only. Furthermore, lactate concentrations 
were measured every two minutes during the treadmill protocol assessment, but due to 
the extensive monitoring of vitals during exercise testing, lactate concentrations were not 
measured every two minutes exactly. When pertaining to those severely compromised by 
their cancer and cancer treatment, some participants did not reach OBLA during the 
protocol, or OBLA was not obviously defined throughout their assessment. As such, if 
OBLA was not obviously measured, OBLA was assumed to be the concentration 
measured at the stage of or the stage before termination (OBLA met a ≥4.0mmol/L 
concentration criteria). In addition, the 12-week exercise intervention included both 
endurance and resistance training and it is unclear whether exercise-mediated effects on 
lactate response in cancer survivors during an exercise bout to volitional fatigue are due 
to endurance training, resistance training, or a combination of both. 
 Finally, the present study included participants with a range of cancer diagnoses 
and stages. As a result, the outcomes of this study may not apply to all cancer diagnoses 
and stages, since cancers can differ in both genotype and phenotype. Future studies 
should be conducted on homogeneous populations of cancer diagnoses and/or stages to 
collect accurate information on the production, accumulation, and disposal of lactate at 
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